The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population

Description

Pathogenic variants in the LRRK2 gene represent the most common cause of autosomal dominant Parkinson’s disease (PD) worldwide. We identified the LRRK2 p.L1795F variant in 14 White/European ancestry PD patients, including two families with multiple affected carriers and seven additional affected individuals with familial PD using genotyping and sequencing data from more than 50,000 individuals through GP2, AMP-PD, PDGENEration, and CENTOGENE. All variant carriers were of White/European ancestry, and those with available genotyping data shared a common haplotype. The clinical presentation of p.L1795F carriers resembles that of other LRRK2 pathogenic variant carriers. Combined with published functional evidence showing strongly enhanced LRRK2 kinase activity, our findings provide conclusive evidence that the LRRK2 p.L1795F variant is pathogenic. It represents a rare cause of PD in the European population but needs to be included in genetic testing efforts and considered for ongoing gene-specific clinical trials.

 

Monogenic - Data Analysis Working Group

The Data Analysis working group carries out core analyses to identify the genetic basis of monogenic forms of Parkinson’s disease.
Learn more about Monogenic - Data Analysis Working Group

Meet the authors

Postdoctoral Fellow, Clinician Scientist

Lara Lange, MD

University of Lübeck and University Medical Center Schleswig-Holstein | Bethesda, MD, USA

Data Scientist

Kristin Levine, MSc

Data Tecnica International | USA

M.S. Student

Nicole Kuznetsov

NIH | USA

Data Scientist

Dan Vitale

National Institutes of Health | USA

Researcher

Hirotaka Iwaki, MD, PhD

Data Tecnica International | USA

Associated Professor

Katja Lohmann, PhD

University of Luebeck | Germany

Movement disorders fellow

Luca Marsili, MD

University of Cincinnati | USA

Professor and Endowed Chair, Principle Investigator

Alberto Espay, MD

University of Cincinnati, University of Cincinnati | Cincinnati, OH, USA

collaborator/contributor

Honglei Chen, MD, PhD

Michigan State University | USA

Lead of Collaborative Research

Hampton Leonard

National Institute on Aging/National Institutes of Health | USA